Table 1. Novel T Cell Immunotherapies Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Novel T Cell Immunotherapies Market Restraints

Table 3. Novel T Cell Immunotherapies Market Trends

Table 4. Novel T Cell Immunotherapies Industry Policy

Table 5. Global Novel T Cell Immunotherapies Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Novel T Cell Immunotherapies Revenue Market Share by Company (2019-2024)

Table 7. Global Novel T Cell Immunotherapies Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Novel T Cell Immunotherapies Mergers & Acquisitions, Expansion Plans

Table 9. Global Novel T Cell Immunotherapies Manufacturers Product Type

Table 10. China Novel T Cell Immunotherapies Revenue by Company (2019-2024) & (US$ million)

Table 11. China Novel T Cell Immunotherapies Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Novel T Cell Immunotherapies Upstream (Raw Materials)

Table 13. Global Novel T Cell Immunotherapies Typical Customers

Table 14. Novel T Cell Immunotherapies Typical Distributors

Table 15. By Type, Global Novel T Cell Immunotherapies Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Novel T Cell Immunotherapies Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Novel T Cell Immunotherapies Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Novel T Cell Immunotherapies Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Novel T Cell Immunotherapies Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Novel T Cell Immunotherapies Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Novel T Cell Immunotherapies Revenue Market Share, 2019-2030

Table 22. Atara Biotherapeutics Company Information, Head Office, Market Area and Industry Position

Table 23. Atara Biotherapeutics Company Profile and Main Business

Table 24. Atara Biotherapeutics Novel T Cell Immunotherapies Models, Specifications and Application

Table 25. Atara Biotherapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 26. Atara Biotherapeutics Recent Developments

Table 27. Allovir Company Information, Head Office, Market Area and Industry Position

Table 28. Allovir Company Profile and Main Business

Table 29. Allovir Novel T Cell Immunotherapies Models, Specifications and Application

Table 30. Allovir Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 31. Allovir Recent Developments

Table 32. Eureka Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 33. Eureka Therapeutics Company Profile and Main Business

Table 34. Eureka Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application

Table 35. Eureka Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 36. Eureka Therapeutics Recent Developments

Table 37. Eutilex Company Information, Head Office, Market Area and Industry Position

Table 38. Eutilex Company Profile and Main Business

Table 39. Eutilex Novel T Cell Immunotherapies Models, Specifications and Application

Table 40. Eutilex Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 41. Eutilex Recent Developments

Table 42. Gammadelta Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 43. Gammadelta Therapeutics Company Profile and Main Business

Table 44. Gammadelta Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application

Table 45. Gammadelta Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 46. Gammadelta Therapeutics Recent Developments

Table 47. Neximmune Company Information, Head Office, Market Area and Industry Position

Table 48. Neximmune Company Profile and Main Business

Table 49. Neximmune Novel T Cell Immunotherapies Models, Specifications and Application

Table 50. Neximmune Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 51. Neximmune Recent Developments

Table 52. Ose Immunotherapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Ose Immunotherapeutics Company Profile and Main Business

Table 54. Ose Immunotherapeutics Novel T Cell Immunotherapies Models, Specifications and Application

Table 55. Ose Immunotherapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 56. Ose Immunotherapeutics Recent Developments

Table 57. Tevogen Bio Company Information, Head Office, Market Area and Industry Position

Table 58. Tevogen Bio Company Profile and Main Business

Table 59. Tevogen Bio Novel T Cell Immunotherapies Models, Specifications and Application

Table 60. Tevogen Bio Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 61. Tevogen Bio Recent Developments

Table 62. Windmil Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 63. Windmil Therapeutics Company Profile and Main Business

Table 64. Windmil Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application

Table 65. Windmil Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024

Table 66. Windmil Therapeutics Recent Developments

List of Figure

Figure 1. Novel T Cell Immunotherapies Picture

Figure 2. Global Novel T Cell Immunotherapies Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Novel T Cell Immunotherapies Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Novel T Cell Immunotherapies Market Share of Global

Figure 5. Global Novel T Cell Immunotherapies Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global Novel T Cell Immunotherapies Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Novel T Cell Immunotherapies Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China Novel T Cell Immunotherapies Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Novel T Cell Immunotherapies Industry Chain

Figure 10. Activated T-cells

Figure 11. Virus Driven T-cells

Figure 12. Tregs

Figure 13. T-cell Vaccines

Figure 14. Others

Figure 15. By Type, Global Novel T Cell Immunotherapies Revenue, 2019-2030, US$ Million

Figure 16. By Type, Global Novel T Cell Immunotherapies Revenue Market Share, 2019-2030

Figure 17. Lung Cancer

Figure 18. Breast Cancer

Figure 19. Cytomegalovirus Infection

Figure 20. Others

Figure 21. By Application, Global Novel T Cell Immunotherapies Revenue, 2019-2030, US$ Million

Figure 22. By Application, Global Novel T Cell Immunotherapies Revenue Market Share, 2019-2030

Figure 23. By Region, Global Novel T Cell Immunotherapies Revenue Market Share, 2019-2030

Figure 24. North America Novel T Cell Immunotherapies Revenue & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, North America Novel T Cell Immunotherapies Revenue Market Share, 2019-2024

Figure 26. Europe Novel T Cell Immunotherapies Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country, Europe Novel T Cell Immunotherapies Revenue Market Share, 2019-2024

Figure 28. Asia Pacific Novel T Cell Immunotherapies Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country/Region, Asia Pacific Novel T Cell Immunotherapies Revenue Market Share, 2019-2024

Figure 30. South America Novel T Cell Immunotherapies Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. By Country, South America Novel T Cell Immunotherapies Revenue Market Share, 2019-2024

Figure 32. Middle East & Africa Novel T Cell Immunotherapies Revenue & Forecasts, 2019-2030, US$ Million

Figure 33. U.S. Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 34. By Company, U.S. Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 35. By Type, U.S. Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 36. By Application, U.S. Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 37. Europe Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 38. By Company, Europe Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 39. By Type, Europe Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 40. By Application, Europe Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 41. China Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 42. By Company, China Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 43. By Type, China Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 44. By Application, China Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 45. Japan Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 46. By Company, Japan Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 47. By Type, Japan Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 48. By Application, Japan Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 49. South Korea Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 50. By Company, South Korea Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 51. By Type, South Korea Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 52. By Application, South Korea Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 53. Southeast Asia Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 54. By Company, Southeast Asia Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 55. By Type, Southeast Asia Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 56. By Application, Southeast Asia Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 57. India Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 58. By Company, India Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 59. By Type, India Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 60. By Application, India Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 61. Middle East & Asia Novel T Cell Immunotherapies Revenue, 2019-2030, (US$ Million)

Figure 62. By Company, Middle East & Asia Novel T Cell Immunotherapies Market Share, 2019-2024

Figure 63. By Type, Middle East & Asia Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 64. By Application, Middle East & Asia Novel T Cell Immunotherapies Revenue Market Share, 2023 VS 2029

Figure 65. Research Methodology

Figure 66. Breakdown of Primary Interviews

Figure 67. Bottom-up Approaches

Figure 68. Top-down Approaches